These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 1805046)
1. Prognostic factors for pleural lymphoma patients. Aozasa K; Ohsawa M; Iuchi K; Mori T; Komatsu H; Tajima K; Minato K; Tajima K; Shimoyama M Jpn J Clin Oncol; 1991 Dec; 21(6):417-21. PubMed ID: 1805046 [TBL] [Abstract][Full Text] [Related]
2. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Iuchi K; Aozasa K; Yamamoto S; Mori T; Tajima K; Minato K; Mukai K; Komatsu H; Tagaki T; Kobashi Y Jpn J Clin Oncol; 1989 Sep; 19(3):249-57. PubMed ID: 2681886 [TBL] [Abstract][Full Text] [Related]
3. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Graff-Baker A; Roman SA; Thomas DC; Udelsman R; Sosa JA Surgery; 2009 Dec; 146(6):1105-15. PubMed ID: 19958938 [TBL] [Abstract][Full Text] [Related]
4. [Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax]. Aozasa K; Ohsawa M Rinsho Ketsueki; 1990 May; 31(5):547-53. PubMed ID: 2395206 [TBL] [Abstract][Full Text] [Related]
5. A single unit lymphoma experience: outcome in a Cape Town academic centre. Wood L; Robinson R; Gavine L; Juritz J; Jacobs P Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma. Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716 [TBL] [Abstract][Full Text] [Related]
7. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens. Villela L; López-Guillermo A; Montoto S; Rives S; Bosch F; Perales M; Ferrer A; Esteve J; Colomo L; Campo E; Montserrat E Cancer; 2001 Apr; 91(8):1557-62. PubMed ID: 11301405 [TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases. Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875 [TBL] [Abstract][Full Text] [Related]
9. Outcome and prognostic factors in ocular adnexal lymphoma. Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428 [TBL] [Abstract][Full Text] [Related]
10. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M). Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782 [TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma]. Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CD44v6 in diffuse large B-cell lymphoma. Inagaki H; Banno S; Wakita A; Ueda R; Eimoto T Mod Pathol; 1999 May; 12(5):546-52. PubMed ID: 10349995 [TBL] [Abstract][Full Text] [Related]
14. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas. Hallermann C; Niermann C; Fischer RJ; Schulze HJ J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214 [TBL] [Abstract][Full Text] [Related]
15. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
16. Factors predicting long-term survival in low-risk diffuse large B-cell lymphoma. Møller MB; Pedersen NT; Christensen BE Am J Hematol; 2003 Oct; 74(2):94-8. PubMed ID: 14508794 [TBL] [Abstract][Full Text] [Related]
17. Spinal epidural involvement in pleural lymphomas developing from long-standing tuberculous pyothorax or pleuritis. Yasuda N; Ohmori S; Usui T Int J Hematol; 1993 Oct; 58(3):177-82. PubMed ID: 8148495 [TBL] [Abstract][Full Text] [Related]
19. Predictive model for prognosis in advanced diffuse histiocytic lymphoma. Danieu L; Wong G; Koziner B; Clarkson B Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors influencing survival in patients with B-cell small lymphocytic lymphoma. Nola M; Pavletic SZ; Weisenburger DD; Smith LM; Bast MA; Vose JM; Armitage JO Am J Hematol; 2004 Sep; 77(1):31-5. PubMed ID: 15307103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]